Obesity and Weight Management for those with or without Diabetes
Type 1 and Type 2 Diabetes:
management of blood glucose, prevention and management of complications
Gestational Diabetes (Diabetes in Pregnancy)
Non Alcoholic Fatty Liver Disease
Dr. Matfin is a Professor of Medicine, MBRU College of Medicine, Dubai, UAE. He graduated from the University of Leeds, UK (M.B. Ch.B with Distinction in Biochemistry and is a Member and Fellow of the Royal College of Physicians. He also has a Master of Science in Experimental Therapeutics from the University of Oxford, UK. He obtained his postgraduate medical training in the UK and USA. This included training in Endocrinology and Diabetes in Newcastle (with Sir George Alberti) and London, UK; as well as the US National Institutes of Health (NIH) working with Pima American Indians.
He is on the UK General Medical Council (GMC) Specialist Register in General Internal Medicine, Diabetes and Endocrinology. He is also American Board of Internal Medicine (ABIM) Board-Certified in General Internal Medicine; and ABIM Board-Certified in Endocrinology, Diabetes and Metabolism, USA.
He is a clinician-educator-researcher with more than 30 years’ experience in General Internal Medicine, Diabetes and Endocrinology gained in the UK, USA and internationally. This includes being Senior Physician and Director of the Inpatient Diabetes Team at the Joslin Diabetes Center, Harvard Medical School, USA; Medical Director and Clinical Professor of Medicine, WHO Collaborating Center for Diabetes, International Diabetes Center and Mayo Clinic, Minnesota, USA; and Consultant Physician, Acute and General Medicine, Diabetes and Endocrinology, NHS, and Honorary Professor of Medicine, Peninsula Medical School, UK.
His major clinical and research interests are in all aspects of General (Internal) Medicine, and Diabetes and Endocrinology. He also has expertise in Type 1 diabetes and the role of new therapies and new technologies (e.g. Continuous Glucose Monitoring [CGM]); and Type 2 diabetes, metabolic syndrome, hypogonadism and CVD complications.
He has made contributions to cardiometabolic research and translation in the UK, USA and internationally. This includes being an ongoing investigator in the landmark study in type 1 diabetes (DCCT/EDIC); Type 1 Diabetes Exchange Clinic Network; and EMPA-REG and LEADER outcome studies (the latter studies published in New England Journal of Medicine). He has published several major textbooks (e.g. Editor, Endocrine and Metabolic Medical Emergencies, published by the US Endocrine Society, 2018; Editor, Lecture Notes: Acute Medicine, in collaboration with RCP Edinburgh, due 2022). He was also Founding Editor-in-Chief in 2010 of Therapeutic Advances in Endocrinology and Metabolism. He has been on various Editorial Boards including the inaugural International Editorial Board to the Lancet Diabetes and Endocrinology; and the inaugural International Editorial Board of the Endocrine Society Open Access publication Journal of the Endocrine Society.
He is a keen and effective educator (e.g. Harvard Medical School Academy Center for Teaching and Learning, Excellence in Tutoring Award, 2011) and is interested in all aspects of undergraduate and postgraduate medical education.
MSc (Oxford), MB ChB, MRCP (UK), ABIM Board Certified in Internal Medicine and Endocrinology